ClinicalTrials.gg
CompletedNCT05883527Updated Oct 26, 2026

Partnership in Safeguarding People With Dementia From Primary and Social Care Perspectives

An observational study in Dementia, Abuse Client and Neglect; Care, Malnutrition, sponsored by University of Manchester. Completed at 5 sites in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University of Manchester · Observational

How we know

Updated Oct 26, 2026Now CompletedResults publication added+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
37
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 178 studies in Dementia with a site in United Kingdom — 39 open to participants now, 58 under way, 12 of them phase 3. Dementia · United Kingdom.

Enrollment
45th of 54
37 · median 210
Started
2023
with 13 others
Observational
54 of 178
20 open now
Registered
133rd of 178
by date

Among the 178 studies in Dementia with a site in United Kingdom, this one is the 45th largest by enrollment of the 54 observational ones that give a count, is one of 14 that started in 2023, is one of 54 observational ones, and was the 133rd registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

39 of the 178 studies in Dementia with a site in United Kingdom are open now. Recruiting first, the newest first:

34 more — sign in →

All 39 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 178 studies in Dementia with a site in United Kingdom, or all of them as a file.
02

Study summary

"Adult safeguarding is everyone's responsibility". The Care Act 2014 makes safeguarding a legal duty. It provides local authorities and other agencies in England with a responsibility to protect adults with care and support needs from abuse and neglect. This is done most effectively when all relevant agencies work together. This is particularly important for people living with dementia, as they are at higher risk of abuse or neglect. Such abuse is most common in their own homes and care settings. Primary and social care professionals are likely to have regular contacts with older people, hence have opportunities for early identification and prevention of abuse. However, little is known about how primary care practitioners work in partnership with social care and other agencies to investigate and manage abuse.

Aims:

This project will outline how health professionals in primary care settings understand and respond to abuse and what their understandings of safeguarding law and policy are. It will also identify how social services departments assess and manage referrals relating to people living with dementia in primary care settings. Furthermore, the study will analyse the experiences of people with dementia and families who are at the centre of safeguarding

Methods:

This study has three phases. In phase 1, the investigators will synthesise current research and practice evidence to develop a theory of safeguarding conceptualisation and process. In phase 2, the investigators will analyse national statistics on safeguarding (NHS digital dataset), ageing and dementia data (English Longitudinal Study of Ageing) to understand patterns of reporting and how they vary across location, gender, ethnicity and time period. In phase 3, the investigators will interview GPs, social workers, safeguarding leads, independent advocates, people with dementia, family members, support workers, carers and other professionals who make or receive referrals via primary care. As part of phase 3 group discussions will also be conducted, in which professionals will come together to share their experiences, and will identify approaches for preventing abuse and collaboration amongst relevant agencies. Phase 3 will inform the development of complex case studies, drawing on data from phases 1 and 2.

Impact:

This study will help develop practice guidance for professionals, to aid multi-agency collaboration in safeguarding cases specific to dementia. This will be developed in consultation with the PPIE (Patient and Public Involvement and Engagement) members and practitioners. Videos will also be produced and plain English versions of case studies of complex safeguarding scenarios and strategies in consultation with safeguarding leads, law experts, training providers and other key stakeholders. Experts by experience (working with, caring for or living with dementia), will be able to guide the team with cultural nuances and appropriateness to ensure that the material developed is sensitive to all populations. An info graph/pictograph displaying signs of abuse, staying safe and what to do, aimed at people with dementia and family will be compiled. The investigators will liaise with national safeguarding leads so that this information can be displayed in GP clinics. Furthermore, the investigators will contact social responsibility personnel for supermarkets and discuss the potentials of wider circulation for displaying this information in stores.

03

Conditions studied

  • Dementia
  • Abuse Client
  • Neglect; Care, Malnutrition

Keywords

  • Safeguarding
  • Abuse
  • Neglect
  • Dementia
  • Health and care professionals
  • Social care
  • Section 42
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Tentatively this study will aim to recruit 20-30 health and social care professionals (interviews-20, focus groups-10) making referrals via GP's who have experiences of safeguarding in the context of dementia. This study also aims to recruit between 15-20 people with dementia and carers/family members involved in safeguarding, who will be accessed via primary and social care practitioners.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Health and social care professionals:

    • GPs, Nurses, social workers, mental health professionals, support workers, IMCA (independent mental capacity advocates) and other health care professionals in GP surgeries and integrated social care hubs with experience in facilitating safeguarding.
    • Safeguarding lead in GP surgeries, social care organisations and other organisations (advocacy agencies).
    • Professionals from third-sector organisations who have previously raised safeguarding concerns regarding adults living with Dementia

Service users and carers/family:

  • People with dementia who have been involved in the safeguarding process, with mental capacity to consent.
  • Family members of people with dementia who have been previously involved in the safeguarding process
  • Individuals who were involved in a safeguarding inquiry in the past, which is NOT ongoing at the time of interview.

Exclusion criteria

Exclusion Criteria:

  • Health and social care professionals at GP practices, social care organisations and third sector organisations without experiences of safeguarding older adults and unwilling to participate in the study.

    • People with dementia who lack capacity to consent.
    • Individuals involved in an active and ongoing safeguarding inquiry.
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
37 participants (actual)
Patient registry
No

Groups and cohorts

  • Health and Care Professionals

    GP's, nurses, social workers, mental health professionals, support workers, Independent mental capacity advocates (IMCA), and other HCP's working in GP surgeries and integrated social care hubs. Safeguarding leads in GP surgeries, social care organisations and other relevant organisations. Professionals from third-sector organisations who have previous experience of safeguarding.

    Other: Not applicable as not an intervention - HCP's

  • People Living with Dementia

    Who have been involved in the safeguarding process and have capacity to consent.

    Other: Not applicable as not an intervention - PLwD and family/carers

  • Paid carers of people living with dementia

    Who have been involved in the safeguarding process.

    Other: Not applicable as not an intervention - PLwD and family/carers

  • Family members of people living with dementia

    Who have been involved in the safeguarding process.

    Other: Not applicable as not an intervention - PLwD and family/carers

Interventions

  • OtherNot applicable as not an intervention - PLwD and family/carers

    Exploring the safeguarding process through interviews.

  • OtherNot applicable as not an intervention - HCP's

    Exploring the safeguarding process through interviews and a focus group.

06

What researchers measure

Primary outcomes

  1. Trends in reporting of routinely collected safeguarding datasets - NHS digital

    Number of reports of safeguarding concerns and section 42 enquiries in England. Type of risks, source of risks, location, age, gender, ethnicity, health condition.

    Time frame: September 2022 - March 2024

  2. Trends in reporting of routinely collected safeguarding datasets - ELSA data

    The prevalence of dementia across England, number of older people with dementia in receipt of care and who gave the care in each local authority in England.

    Time frame: data years: 2002-2017

  3. Quality Outcomes Framework (QOF) Recorded Dementia Diagnoses

    Rate of dementia diagnosis in each local authority district in England and demographic characteristics of those with dementia diagnosis in each NHS CCG in England.

    Time frame: data years: 2021-2022

Other outcomes

  1. Contexts, Mechanisms and Outcomes (CMO's) from the Rapid Realist Literature Review

    The rapid realist review will investigate how health \& social care professionals conceptualise and respond to risks of abuse and neglect involving people with dementia in England, UK. The review will be informed by Rameses guidelines and aims to develop initial programme theories.

    Time frame: September 2022 - March 2024

  2. Interpretative Phenomenological Analysis (IPA) of Interviews

    IPA of interview transcripts will lead to an in-depth understanding of the lived experiences of safeguarding from the perspective of health and social care professionals, people living with dementia, family caregivers and other relevant professionals.

    Time frame: September 2022 - March 2024

  3. Interpretative Phenomenological analysis (IPA) of Focus Group - with health and care professionals

    Lived experiences of safeguarding from the perspective of various professionals, including what worked, what did not work, understanding of legal thresholds, strategies for prevention and collaboration across agencies.

    Time frame: September 2022 - March 2024

07

Study locations

5 sites
  • CRN
    Leeds, United Kingdom
  • Leeds Local Authority
    Leeds, United Kingdom
  • CRN
    Manchester, United Kingdom
  • Greater Manchester Local Authority
    Manchester, United Kingdom
  • CRN
    Southport, United Kingdom
08

References and documents

Publications

  • Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns among older adults with dementia in England: a population-based repeated cross-sectional study. BMJ Open. 2026 Aug 26;16(8):e110575. doi: 10.1136/bmjopen-2025-110575. PubMed 42648775 ↗
  • Lasrado R, Szulewska K, Dixon J, Maharani A, Robinson C, Cooper M, Panagioti M, Blakeman T. Understanding Safeguarding for People Living with Dementia: A Realist Review of Conceptualization and Practice. Trauma Violence Abuse. 2025 Oct 21:15248380251375488. doi: 10.1177/15248380251375488. Online ahead of print. PubMed 41117016 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from May 2023 to primary completion in Feb 2024, 9 months.

Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2023 → Feb 2024, on Oct 26, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 10, 2023
First posted
Jun 1, 2023
StartActual
May 1, 2023
Primary completionActual
Feb 6, 2024was Aug 2023
CompletionActual
Mar 31, 2024
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 26, 2026
Primary completion
Aug 2023→Feb 6, 2024 (actual)
Oct 26, 2026
Enrollment
50 (estimated)→37 (actual)
Oct 26, 2026
Publications
Results publication added: Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns amo… PubMed 42648775 ↗; 1 more
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Recruiting→Completed
    Publications Results publication added: Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns amo… PubMed 42648775 ↗; 1 more
    Primary completion Aug 2023→Feb 6, 2024 (now actual)
    Enrollment 50 (estimated)→37 (actual)
    + 4 other changes: verification date, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05883527
Responsible party
Reena Lasrado (Principal Investigator, University of Manchester) — Principal investigator
First posted
Jun 1, 2023
Start date
May 1, 2023
Primary completion
Feb 6, 2024
Completion
Mar 31, 2024
Last update
Oct 26, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion